19 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
11 Apr 24
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
9:00am
. Analysis of resected tumors showed treatment with CAN-2409 modified the tumor microenvironment, with the local recruitment and activation of cytotoxic
8-K
EX-99.1
y0o b2o83ub
6 Dec 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
r0smpulrko
6 Jun 22
Regulation FD Disclosure
8:37am
10-K
rn2un
29 Mar 22
Annual report
8:46am
10-Q
gu26fo3ssmy4t8o
8 Sep 21
Quarterly report
8:37am
424B4
lv5uqbu20ay0sqhv
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
5pljs wtm9376
16 Jul 21
IPO registration (amended)
6:07am
S-1
q2g30dxr2ws2 yr6k
25 Jun 21
IPO registration
5:28pm
DRS/A
mmbucya0
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next